Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities
- 2 November 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (22), 7228-7235
- https://doi.org/10.1021/jm901278z
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Licochalcone A Potently Inhibits Tumor Necrosis Factor α-Induced Nuclear Factor-κB Activation through the Direct Inhibition of IκB Kinase Complex ActivationMolecular Pharmacology, 2009
- Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB–regulated gene products and potentiation of apoptosis in leukemia cellsBlood, 2009
- Inflammation and cancer: Role of nuclear factor‐kappaB activationCancer Science, 2008
- Sites of alkylation of human Keap1 by natural chemoprevention agentsJournal of the American Society for Mass Spectrometry, 2007
- Chalcone Arrests Cell Cycle Progression and Induces Apoptosis through Induction of Mitochondrial Pathway and Inhibition of Nuclear Factor Kappa B Signalling in Human Bladder Cancer CellsBasic & Clinical Pharmacology & Toxicology, 2007
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the ProteasomeMolecular Pharmacology, 2006
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Inflammation and cancerNature, 2002
- Inhibitory effect of herbal remedies on 12-o-tetradecanoylphorbol-13-acetate-promoted Epstein–Barr virus early antigen activationPharmacological Research, 2002